Your browser doesn't support javascript.
loading
[Is there any interest to dose the azathioprine's metabolites during inflammatory bowel diseases?]. / Y a-t-il intérêt à doser les métabolites de l'azathioprine chez les malades ayant une maladie inflammatoire chronique de l'intestin ?
Melaouhia, Salma; Fékih, Monia; Ferchichi, Henda; Bouissorra, Houda; Ben Mustapha, Nadia; Boubaker, Jalel; Filali, Azza; Lakhal, Mohamed; Klouz, Anis.
Affiliation
  • Melaouhia S; Service de Pharmacologie clinique, Centre national de Pharmacovigilance, Tunis, Tunisie.
Therapie ; 68(5): 313-20, 2013.
Article in Fr | MEDLINE | ID: mdl-24225042
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azathioprine / Colitis, Ulcerative / Crohn Disease / Immunosuppressive Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: Fr Journal: Therapie Year: 2013 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Azathioprine / Colitis, Ulcerative / Crohn Disease / Immunosuppressive Agents Type of study: Observational_studies / Prognostic_studies Limits: Adult / Female / Humans / Male / Middle aged Language: Fr Journal: Therapie Year: 2013 Document type: Article Affiliation country: Country of publication: